8852
-
Lung Cancer: Targets and Therapy
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Lung Cancer: Targets and Therapy
(94,102) Views
Editor in Chief Pan-Chyr Yang, MD
1179-2728
Original ResearchA pilot study of a metronomic chemotherapy regimen with weekly low-dose docetaxel for previously treated non-small cell lung cancer
Yokoi T, Tamaki T, Shimizu T, Nomura S
Lung Cancer: Targets and Therapy 2012, 3:15-20
18 May 2012
Review
Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer
Zienolddiny S, Skaug V
Lung Cancer: Targets and Therapy 2012, 3:1-14
30 December 2011
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
